Shopping Cart
- Remove All
Your shopping cart is currently empty
Prasinezumab is a monoclonal antibody that selectively binds aggregated α-synuclein. Prasinezumab is under investigation as a disease-modifying therapeutic candidate for early-stage Parkinson’s disease, where it is being evaluated for its ability to interfere with pathogenic α-synuclein aggregation and progression of neurodegeneration.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $373 | In Stock | |
| 5 mg | $1,120 | In Stock | |
| 10 mg | $1,790 | In Stock |
| Description | Prasinezumab is a monoclonal antibody that selectively binds aggregated α-synuclein. Prasinezumab is under investigation as a disease-modifying therapeutic candidate for early-stage Parkinson’s disease, where it is being evaluated for its ability to interfere with pathogenic α-synuclein aggregation and progression of neurodegeneration. |
| Synonyms | RO7046015, RO 7046015, RG7935, RG 7935, PRX002, PRX 002 |
| Cas No. | 1960462-19-4 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.